These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36436877)

  • 1. Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound.
    Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
    J Atheroscler Thromb; 2023 Sep; 30(9):1142-1151. PubMed ID: 36436877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Baseline and Postprocedural Intravascular Ultrasound Findings on 1-Year Primary Patency After Drug-Coated Balloon Treatment of Femoropopliteal Lesions.
    Horie K; Tanaka A; Taguri M; Inoue N
    J Endovasc Ther; 2022 Feb; 29(1):66-75. PubMed ID: 34781756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of the Size of Drug-Coated Balloon Therapy on Restenosis Rate in Femoropopliteal Lesions.
    Kurata N; Iida O; Takahara M; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Hata Y; Mano T
    J Endovasc Ther; 2023 Apr; 30(2):269-280. PubMed ID: 35249409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of postprocedural minimum lumen area on clinical outcome after femoropopliteal drug-eluting stent implantation.
    Haraguchi T; Takahara M; Iida O; Soga Y; Yamaoka T; Fujihara M; Kawasaki D; Ichihashi S; Kozuki A; Sato K; Fujita T
    Vasc Med; 2023 Oct; 28(5):412-421. PubMed ID: 37554116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Intravascular Ultrasound Measurement Values Between Treatment Modalities for Restenosis in Femoropopliteal Lesions.
    Aihara H; Higashitani M; Takimura H; Tobita K; Jujo K; Hozawa K; Yamaguchi T; Iwata Y; Tokuyama H; Sakurai M; Murata N; Fujimoto Y; Kikuchi A; Koganei H; Sato A; Noguchi Y; Ieda M
    Circ J; 2020 Jul; 84(8):1320-1329. PubMed ID: 32581151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumen Gain After Endovascular Therapy in Calcified Superficial Femoral Artery Occlusive Disease Assessed by Intravascular Ultrasound (CODE Study).
    Fujihara M; Kozuki A; Tsubakimoto Y; Takahara M; Shintani Y; Fukunaga M; Iwasaki Y; Nakama T; Yokoi Y
    J Endovasc Ther; 2019 Jun; 26(3):322-330. PubMed ID: 30873909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter, retrospective registry of isolated atherosclerotic popliteal arteries treated with endovascular revascularization.
    Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
    Heart Vessels; 2023 Sep; 38(9):1117-1129. PubMed ID: 37217811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Intravascular Ultrasound-Guided Fluoropolymer-Based Drug-Eluting Stent Implantation for Femoropopliteal Lesions.
    Tsujimura T; Iida O; Takahara M; Soga Y; Yamaoka T; Fujihara M; Kawasaki D; Ichihashi S; Kozuki A; Nanto S; Sakata Y; Mano T;
    JACC Cardiovasc Interv; 2022 Aug; 15(15):1569-1578. PubMed ID: 35926923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
    J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Intravascular Ultrasound on Femoropopliteal Artery Endovascular Interventions: A Randomized Controlled Trial.
    Allan RB; Puckridge PJ; Spark JI; Delaney CL
    JACC Cardiovasc Interv; 2022 Mar; 15(5):536-546. PubMed ID: 35272779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Dissection Angles as Predictor of Restenosis after Drug-Coated Balloon Treatment.
    Kozuki A; Takahara M; Shimizu M; Kijima Y; Nagoshi R; Fujiwara R; Shibata H; Suzuki A; Soga F; Miyata T; Sakamoto Y; Seo H; Asada H; Isawa K; Higuchi K; Shite J
    J Atheroscler Thromb; 2021 Sep; 28(9):954-962. PubMed ID: 33100279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between physiological assessment and imaging findings during drug-coated balloon treatment for femoropopliteal diseases.
    Iwasaki Y; Shimada T; Sato T; Koike J; Funatsu A; Kobayashi T; Ikeda T; Nakamura S
    Cardiovasc Revasc Med; 2024 Mar; 60():66-71. PubMed ID: 37739885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
    Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
    J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
    [No Abstract]   [Full Text] [Related]  

  • 19. Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion.
    Soga Y; Takahara M; Iida O; Tomoi Y; Kawasaki D; Tanaka A; Yamauchi Y; Tobita K; Kozuki A; Fujihara M; Ando K;
    J Am Heart Assoc; 2023 Jan; 12(1):e025677. PubMed ID: 36583431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
    JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.